![M. Wilsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Wilsey
Ordförande på
SAREPTA THERAPEUTICS, INC.
Förmögenhet: 6 M $ per 2026-08-31
Profil
Dr. M.
K.
Wilsey is a Chairman at MiMedx Group, Inc. and a Chairman at Sarepta Therapeutics, Inc. Dr. Wilsey was previously employed as an Independent Director by IGM Biosciences, Inc., an Independent Director by Amylin Pharmaceuticals, Inc., a President & Chief Executive Officer by KEW Group, Inc., a Member by President's Council of Advisors on Science & Technology, a Managing Director by RS Investment Management Co. LLC, a Chairman & President by National Venture Capital Association, a Managing Director & General Partner by Robertson Stephens & Co., and a Co-Founder by The Coalition for 21st Century Medicine.
She also served on the board at Abgenix, Inc. and Board On Science Technology & Economic Policy.
She received her undergraduate degree from the University of California, Davis and a doctorate degree from the University of California, Davis.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-04 | 224 357 ( 0,21 % ) | 5 M $ | 2026-08-31 | |
MIMEDX GROUP, INC. 0,15 % | 2025-06-18 | 212 771 ( 0,15 % ) | 965 980 $ | 2026-08-31 |
Aktiva positioner av M. Wilsey
| Företag | Position | Start |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Ordförande | 2015-04-16 |
| MIMEDX GROUP, INC. | Ordförande | 2019-06-19 |
Tidigare kända positioner av M. Wilsey
| Företag | Position | Slut |
|---|---|---|
| IGM BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2025-08-14 |
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Verkställande Direktör | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Direktör/Styrelseledamot | 2012-08-08 |
RS Investment Management Co. LLC
 RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Företagsledare/Principal | 2009-12-01 |
President's Council of Advisors on Science & Technology
 President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Företagsledare/Principal | 2009-01-01 |
M. Wilseys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
83
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
RS Investment Management Co. LLC
RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Finance |
Robertson Stephens & Co.
 Robertson Stephens & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
President's Council of Advisors on Science & Technology
President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Government |
MiMedx Group, Inc.
 MiMedx Group, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets patent protected regenerative biomaterial products and bioimplants | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
The Coalition for 21st Century Medicine
 The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine is a collaborative organization representing diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists, and patient advocacy groups. The non-profit company is based in Arlington, VA. It is dedicated to advancing the development, commercialization, and adoption of molecular and genomic diagnostic technologies that enable personalized medicine, improve patient outcomes, and reduce healthcare costs. The coalition engages with policymakers to shape regulatory, reimbursement, and intellectual property policies supporting innovation in diagnostic medicine, advocates for balanced regulatory frameworks, opposes burdensome regulations on laboratory-developed tests, and promotes patent predictability. It addresses issues such as patent eligibility, Medicare payment modernization, and expanded coverage for advanced diagnostic assays, and regularly submits comments, position statements, and amicus briefs to protect intellectual property rights and improve patient access. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, Patrick F. Terry. | Commercial Services |
Board On Science Technology & Economic Policy | |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
